ESCRS - Macular disease and cataracts: Threshold for surgery should be low ;
ESCRS - Macular disease and cataracts: Threshold for surgery should be low ;

Macular disease and cataracts: Threshold for surgery should be low

Macular disease and cataracts: Threshold for surgery should be low
Dermot McGrath
Dermot McGrath
Published: Monday, September 26, 2016
congress-news_wolf_2096 Cataract surgery in patients with macular disease should be performed if the patient has cataract-related visual symptoms, according to Sebastian Wolf MD, PhD. “The take-home message is that the threshold for cataract surgery should be low and even patients with reduced visual potential may benefit from cataract surgery,” Dr Wolf told delegates attending yesterday’s ESCRS Clinical Research Symposium on cataract and macular disease in Copenhagen. Dr Wolf, of Switzerland, said that the question of whether cataract surgery is safe for someone with age-related macular degeneration (AMD) or other retinal disease is regularly posed by both patients and their treating physicians. While patients often worry that having the surgery will worsen their disease, there is no clear evidence that cataract surgery promotes AMD progression, he said. Dr Wolf said that cataract surgery is indicated when vision loss interferes with everyday activities. “We need to remember that cataract removal is one of the most common, safest and effective operations in medicine. In more than 90% of cases, people who have cataract surgery have better vision afterwards. Cataract surgery does, however, increase the risk of retinal detachment and it is true that the interaction between macular disease and cataract surgery is still very much under discussion,” he said. In terms of diagnostics that best predict the risk-benefit curve in patients with cataract and macular disease, Dr Wolf warned that ophthalmoscopy may be compromised by the presence of cataract. By contrast, optical coherence tomography (OCT) is also particularly useful in such patients, he said. “We typically use OCT, and the big advantage of this is that infrared light can penetrate even dense nuclear cataracts and give us a clearer view of the retina and macula,” he added.    
Latest Articles
Glaucoma Treatment Under Pressure

New techniques and technologies add to surgeons’ difficult decisions

Read more...

Outside the Box, Inside the Pipeline

Researchers are tackling glaucoma diagnosis and treatment from all sides.

Read more...

The EHDS Is Ready for the Green Light

If proposal is approved, Europe could see better access to, and exchange and use of, health data.

Read more...

ESCRS to Release Guidelines for Cataract and Refractive Surgery

Comprehensive approach to the safest and most effective modern surgery.

Read more...

Barry Fellowship Opens Up ‘Whole New Field of Thought’

The 2022 recipient combines theoretical and practical to learn new treatments.

Read more...

Digitalising the OR—Experience and Perspectives

Benefits include saving time and improving outcomes.

Read more...

ESCRS Heritage Programme

Visionaries past and present.

Read more...

Dynamic Measures Needed for Quality of Vision

Functional visual acuity testing and straylight metering may better reflect real-world conditions.

Read more...

What Is Stopping Digital OR Adoption?

Ophthalmologists know the benefits—now it’s time to construct the right plan.

Read more...

Time to Move Beyond Monofocal IOLs?

European surgeons appear hesitant to first offer other presbyopia-correcting options to patients.

Read more...

;